LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 6 of 15: End-point mean cell counts and mean normalized growth rate inhibition values for biological replicate 3. - Dataset (ID:20314)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 55.10 | 56.33 | 733 | 6087 | 0.1216 | 0.3693 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 56.80 | 56.33 | 770 | 6354 | 0.1230 | 0.3777 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 58.50 | 56.33 | 762 | 6599 | 0.1175 | 0.3691 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 60.20 | 56.33 | 781 | 6852 | 0.1165 | 0.3712 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 61.90 | 56.33 | 782 | 7075 | 0.1129 | 0.3683 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 63.60 | 56.33 | 804 | 7339 | 0.1121 | 0.3621 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 65.30 | 56.33 | 816 | 7570 | 0.1102 | 0.3681 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 67.00 | 56.33 | 817 | 7731 | 0.1084 | 0.3678 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 68.70 | 56.33 | 819 | 7933 | 0.1056 | 0.3620 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 70.50 | 56.33 | 822 | 7990 | 0.1053 | 0.3628 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 72.20 | 56.33 | 822 | 8053 | 0.1042 | 0.3626 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 73.90 | 56.33 | 837 | 8150 | 0.1051 | 0.3643 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 75.60 | 56.33 | 845 | 7992 | 0.1075 | 0.3630 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 77.30 | 56.33 | 840 | 8135 | 0.1050 | 0.3625 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 79.00 | 56.33 | 878 | 8048 | 0.1109 | 0.3637 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 80.70 | 56.33 | 854 | 7920 | 0.1089 | 0.3574 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 82.40 | 56.33 | 869 | 7810 | 0.1121 | 0.3616 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 84.10 | 56.33 | 874 | 7655 | 0.1145 | 0.3637 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 85.80 | 56.33 | 883 | 7583 | 0.1166 | 0.3630 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 87.50 | 56.33 | 896 | 7334 | 0.1222 | 0.3702 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 89.20 | 56.33 | 885 | 7229 | 0.1223 | 0.3630 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 90.90 | 56.33 | 892 | 7174 | 0.1242 | 0.3550 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 92.60 | 56.33 | 895 | 7065 | 0.1266 | 0.3617 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 94.30 | 56.33 | 896 | 6924 | 0.1293 | 0.3562 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 95.70 | 27.76 | 799 | 6712 | 0.1191 | 0.3824 |